Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1867 (1) , 165966
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2017YFC1201200)
This publication has 28 references indexed in Scilit:
- Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate CancerMolecular & Cellular Proteomics, 2016
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- Identification of genomic alterations in oesophageal squamous cell cancerNature, 2014
- A Novel Aldehyde Dehydrogenase-3 Activator (Alda-89) Protects Submandibular Gland Function from Irradiation without Accelerating Tumor GrowthClinical Cancer Research, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell EnrichmentIn VivoClinical Cancer Research, 2011
- In Vivo Neurochemical Monitoring Using Benzoyl Chloride Derivatization and Liquid Chromatography–Mass SpectrometryAnalytical Chemistry, 2011
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinomaSurgery, 2003